查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1802952

益生菌生物膜保護劑市場預測（至 2032 年）：按產品類型、應用、最終用戶和地區進行的全球分析

Probiotic Biofilm Protectors Market Forecasts to 2032 - Global Analysis By Product Type (Probiotic Strains, Postbiotics & Synbiotics and Delivery Formats), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球益生菌生物膜保護劑市場預計在 2025 年價值 17.3 億美元，到 2032 年將達到 47.6 億美元，預測期內的複合年成長率為 15.5%。

益生菌生物膜保護劑是生長在皮膚、口腔和胃等黏膜表面的有益細菌，它們會形成一層稱為生物膜的保護層。這種生物膜可作為生物和物理屏障，防止危險病原體附著、定植並引起感染疾病。與通常與疾病相關的致病性生物膜不同，益生菌生物膜透過增強免疫力、產生抗菌化合物和穩定微生物群來增強人體的防禦能力。它們還能減輕發炎、促進組織修復並維持屏障完整性。

Cochrane系統綜述與總結統合分析發現，益生菌可降低抗生素相關性腹瀉 (AAD) 的風險。兒童的總估計值值為相對風險 0.46（95% CI 0.35-0.61），在基準風險為中等的試驗中，NNT 約為 10。

消費者對免疫支持和腸道健康的認知不斷提高

隨著人們日益意識到腸道菌叢對整體健康的重要性，益生菌生物膜保護劑的需求也隨之成長。消費者擴大尋求自然療法來增強免疫系統功能、平衡消化系統並預防疾病，尤其是在壓力、肥胖和抗生素濫用等生活方式相關的健康問題損害腸道健康的情況下。新冠疫情激發了人們對日常益生菌消費的興趣，並提高了全球對其免疫恢復能力的認知。此外，益生菌生物膜保護劑由於其在腸道中更強大的定植和存活能力，能夠為消費者帶來比傳統益生菌更持久的益處。

研發成本高

高昂的研發成本是限制益生菌生物膜保護劑市場的主要因素之一。與傳統益生菌不同，以生物膜為基礎的產品需要菌株工程、封裝和微生物組分析等最尖端科技，以確保穩定性、安全性和有效性。進行證明功效和合規性所需的臨床前和臨床試驗成本極為高昂。由於缺乏資金，中小企業往往難以競爭，而大型企業則面臨著證明其研發投資已產生效益的壓力。

擴大皮膚護膚和皮膚病學的應用

除了腸道健康之外，益生菌生物膜保護劑在皮膚科和化妝品科學領域也擁有巨大的潛力。某些益生菌菌株已被證明能夠在皮膚表面形成生物膜，增強皮膚屏障功能，減少病原體定植，並增強皮膚微生物群。這為治療牛皮癬、痤瘡、濕疹和過早老化的局部治療開闢了新的途徑。以生物膜為基礎的益生菌還可以透過提供持久的保護作用來提升化妝品乳液、精華液和乳霜的功效。微生物組美容的興起以及消費者對有科學依據的天然護膚產品的需求，為產品多樣化提供了重要的機會。化妝品品牌和生技公司可以合作開發生物膜益生菌，並將護膚轉變為微生物組主導的療法。

價格壓力大，市場競爭激烈

益生菌生物膜保護劑市場正面臨新興和成熟益生菌生產商的激烈競爭，這些生產商紛紛提供以微生物組為基礎的替代品。由於傳統益生菌價格更實惠、更容易取得，基於生物膜的產品在維持高價位方面面臨挑戰。此外，微生物組調節劑、後生元、合益素和益生元的快速崛起，擴大了消費者的選擇，也加劇了競爭。市場佔有率很可能被擁有更龐大分銷網路和資源的跨國公司所主導，從而限制了小型創新企業的機會。這種競爭環境可能導致價格戰，降低利潤率，並推遲對新創意的投資，尤其是對於那些尋求推廣創新基於生物膜的益生菌產品的新興企業而言。

COVID-19的影響：

新冠疫情既是催化劑，也是挑戰，對益生菌生物膜保護劑市場產生了重大影響。在需求方面，這場危機提高了全球對免疫力、腸道健康和預防性保健的認知，激發了消費者對功效得到證實的益生菌的興趣。隨著健康意識的增強，以生物膜為基礎的益生菌因其比傳統菌株更優異的保護效果、更長的定植期和更高的存活率而越來越受歡迎。供應鏈中斷、原料短缺以及封鎖期間的物流困難是市場必須克服的一些挑戰。儘管面臨這些挫折，新冠疫情最終還是透過將益生菌生物膜保護劑確立為膳食補充劑和機能性食品中關鍵的免疫支持創新，增加了長期需求。

食品和飲料保鮮市場預計將成為預測期內最大的市場

預計食品和飲料保鮮領域將在預測期內佔據最大的市場佔有率。這種主導地位是由對富含益生菌的膳食補充劑、乳製品替代品、發酵飲料和機能性食品不斷成長的需求所驅動的。生物膜衍生的益生菌非常適合加入消費食品中，因為它們具有出色的貨架穩定性、耐受惡劣加工條件的能力以及在消化和儲存過程中的高存活率。消費者對天然、潔淨標示和增強免疫力產品的偏好日益成長，進一步推動了該市場的應用。此外，食品製造商和生物技術公司之間的合作使富含益生菌的產品更加廣泛地普及，確保食品和飲料仍然是市場的主要成長引擎。

預計預測期內消費者健康和保健領域將以最高的複合年成長率成長。

預計消費者健康與保健領域將在預測期內實現最高成長率。全球對腸道菌叢平衡、增強免疫力和預防性醫療保健的日益關注，推動了注重健康的消費者對益生菌的需求成長。基於生物膜的益生菌在這個市場中獨樹一幟，因為它們比傳統益生菌具有更高的活力、更長的定植時間和更持久的效果。機能性食品的日益普及，也推動了益生菌的普及。

佔比最大的地區：

預計亞太地區將在預測期內佔據最大的市場佔有率，這得益於快速的都市化、日益增強的健康意識以及對發酵食品的文化接受度。益生菌相關的良好飲食習慣以及中等收入人口成長帶來的可支配收入的提高，推動了益生菌需求的成長，其中中國、日本、韓國和印度等國家的需求最高。政府支持預防性醫療保健和機能性食品的計畫正在進一步加速其普及。不斷擴大的研發支出、區域製造以及廣泛的零售和電子商務分銷網路進一步支持了該地區的市場成長。此外，由於消費者群體多樣化以及對免疫力和健康的日益關注，亞太地區仍然是全球益生菌生物膜保護劑消費的領先地區。

複合年成長率最高的地區：

在預測期內，由於微生物組研究的快速發展、消費者對預防性醫療保健的高需求以及膳食補充劑和機能性食品的日益普及，北美預計將實現最高的複合年成長率。該地區高度發達的醫療保健基礎設施以及對益生菌創新和基於生物膜的遞送系統不斷增加的投資，推動了益生菌的快速普及。隨著人們對免疫力、腸道健康和個人化營養的認知不斷提高，尤其是透過優質補充劑和強化食品，市場滲透率進一步提升。此外，製藥、食品和生技公司之間的策略聯盟也增加了產品的供應。

免費客製化服務：

此報告的訂閱者可以使用以下免費自訂選項之一：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 二手研究資料
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球益生菌生物膜保護劑市場（依產品類型）

  • 益生菌菌株
    • 芽孢桿菌菌株
    • 乳酸菌菌株
    • 雙歧桿菌菌株
  • 後生元和合合益素
  • 交貨方式
    • 膠囊
    • 粉末
    • 機能性食品
    • 外用凝膠/乳膏
    • 液體懸浮液
    • 微膠囊形式

6. 全球益生菌生物膜保護劑市場（依應用）

  • 醫療設備生物膜保護
  • 食品和飲料儲存
  • 農產品保護
  • 環境和工業清潔
  • 其他用途
    • 水產養殖
    • 獸醫健康
    • 口腔衛生
    • 纖維和表面塗層

7. 全球益生菌生物膜保護劑市場（按最終用戶）

  • 醫院和診所
  • 製藥公司
  • 消費者健康與保健
  • 研究機構
  • 個人護理和化妝品
  • 獸醫診所和動物醫療公司

8. 全球益生菌生物膜保護劑市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第9章：主要進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章：企業概況

  • Chr Hansen Holding AS
  • Kerry Group PLC
  • DuPont de Nemours, Inc.
  • BioGaia AB
  • Nestle SA
  • DSM-Firmenich
  • Lifeway Foods Inc.
  • Yakult Honsha Co., Ltd.
  • Danone SA
  • Lallemand Inc.
  • General Mills Inc.
  • PepsiCo Inc.
  • Nuron Biotech Inc.
  • Walvax Biotechnology Co., Ltd.
  • Morinaga Milk Industry Co. Ltd
  • Sanzyme Biologics Pvt. Ltd.
  • Now Foods
Product Code: SMRC30478

According to Stratistics MRC, the Global Probiotic Biofilm Protectors Market is accounted for $1.73 billion in 2025 and is expected to reach $4.76 billion by 2032 growing at a CAGR of 15.5% during the forecast period. Probiotic biofilm protectors are good bacteria that grow on mucosal surfaces like the skin, mouth, or stomach to create a protective layer called a biofilm. In order to stop dangerous pathogens from adhering, colonizing, and causing infections, this biofilm serves as a biological and physical barrier. In contrast to pathogenic biofilms, which are frequently linked to illness, probiotic biofilms strengthen the body's defenses by boosting immunity, generating antimicrobial compounds, and stabilizing the microbiota. They also lessen inflammation, encourage tissue repair, and preserve the integrity of the barrier.

According to Cochrane systematic reviews and pooled meta-analyses, probiotics reduce the risk of antibiotic-associated diarrhea (AAD); pooled estimates in children show a relative risk ≈0.46 (95% CI ~0.35-0.61) with an approximate NNT ≈10 in trials with moderate baseline risk.

Market Dynamics:

Driver:

Growing consumer knowledge of immune support and gut health

Growing awareness of the importance of the gut microbiota to general health is driving up demand for probiotic biofilm protectors. Consumers are increasingly looking for natural remedies for immune system function, digestive balance, and disease prevention, particularly as lifestyle-related health problems like stress, obesity, and antibiotic overuse impair gut health. Interest in taking probiotics on a daily basis increased as a result of the COVID-19 pandemic, which also raised awareness of immune resilience worldwide. Additionally, probiotic biofilm protectors provide longer-lasting benefits to consumers than traditional probiotics because of their superior capacity to colonize and remain in the gut.

Restraint:

High expenses of research and development

The high cost of research and development is one of the main factors limiting the market for probiotic biofilm protectors. In contrast to traditional probiotics, biofilm-based products require cutting-edge technologies like strain engineering, encapsulation, and microbiome analytics to guarantee stability, safety, and effectiveness. Preclinical and clinical trials, which are required to demonstrate benefits and regulatory compliance, are extremely expensive to conduct. Due to a lack of funding, smaller businesses frequently find it difficult to compete, while larger firms are under pressure to demonstrate that their R&D expenditures have produced profitable results.

Opportunity:

Expanding uses in skincare and dermatology

Probiotic biofilm protectors have enormous potential in dermatology and cosmetic science, in addition to gut health. Certain probiotic strains have been shown to be able to create biofilms on the skin's surface, enhancing barrier function, lowering pathogenic colonization, and fortifying the skin's microbiome. This makes room for topical treatments that address psoriasis, acne, eczema, and early aging. Probiotics based on biofilms can also improve the efficacy of cosmetic lotions, serums, and creams by providing longer-lasting protection. A significant opportunity for product diversification is presented by the emergence of "microbiome beauty" and consumer demand for natural skincare products supported by science. Cosmetic brands and biotech companies could collaborate to develop biofilm probiotics, which could turn skincare into microbiome-driven treatments.

Threat:

High levels of price pressure and market competition

The market for probiotic biofilm protectors is seriously threatened by fierce competition from both new and established probiotic producers who are providing microbiome-based alternatives. Because conventional probiotics are still more affordable and accessible, biofilm-based products find it challenging to defend their premium pricing. Furthermore, the quick ascent of microbiome modulators, postbiotics, synbiotics, and prebiotics broadens consumer choices and intensifies competition. Market share can be dominated by multinational corporations with larger distribution networks and resources, which restricts the opportunities for smaller innovators. Price wars could result from this competitive climate, reducing profit margins and delaying investment in new ideas, especially for startups looking to market innovative biofilm-based probiotic products.

Covid-19 Impact:

The COVID-19 pandemic acted as a catalyst and a challenge, significantly affecting the market for probiotic biofilm protectors. On the demand side, the crisis intensified consumer interest in probiotics with demonstrated efficacy by raising awareness of immunity, gut health, and preventive wellness on a global scale. As health consciousness has increased, biofilm-based probiotics have gained popularity because they provide better protection, longer colonization times, and increased survivability than traditional strains. Supply chain interruptions, shortages of raw materials, and logistical difficulties in distribution during lockdowns were some of the challenges the market had to overcome. COVID-19 ultimately increased long-term demand by establishing probiotic biofilm protectors as important immune-supporting innovations in nutraceuticals and functional foods, despite these setbacks.

The food and beverages preservation segment is expected to be the largest during the forecast period

The food and beverages preservation segment is expected to account for the largest market share during the forecast period. The growing demand for probiotic-fortified nutraceuticals, dairy substitutes, fermented drinks, and functional foods is what is causing this dominance. Probiotics derived from biofilms have excellent shelf stability, resistance to severe processing conditions, and increased survivability during digestion and storage, which makes them perfect for incorporation into consumer foods. Adoption in this market has been further accelerated by rising consumer preference for natural, clean-label and immunity-boosting products. Additionally, probiotic-enriched products are becoming more widely available owing to partnerships between food manufacturers and biotech companies, guaranteeing that food and beverages will continue to be the market's main growth engine.

The consumer health & wellness segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the consumer health & wellness segment is predicted to witness the highest growth rate. Growing awareness of gut microbiome balance, immunity enhancement, and preventive healthcare around the world is driving high demand from consumers who are concerned about their health. In this market, biofilm-based probiotics are unique because they are more survivable, colonize for longer periods of time, and provide longer-lasting benefits than traditional probiotics. The growing accessibility of functional foods, probiotic-enriched supplements, and beverages designed for everyday well-being is propelling widespread adoption.

Region with largest share:

During the forecast period, the Asia-Pacific region is expected to hold the largest market share, driven by its rapid urbanization, rising health consciousness, and ingrained cultural acceptance of fermented foods. Strong probiotic-related dietary traditions and growing disposable incomes among growing middle-class populations support demand, which is highest in countries like China, Japan, South Korea, and India. Adoption is further accelerated by government programs supporting preventive healthcare and functional foods. The region's market growth is further supported by expanding R&D expenditures, regional manufacturing, and extensive retail and e-commerce distribution networks. Furthermore, Asia-Pacific continues to be the world's leading region for the consumption of probiotic biofilm protectors due to its wide range of consumers and growing emphasis on immunity and wellness.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by the quick development of microbiome research, the high demand from consumers for preventive healthcare, and the growing acceptance of nutraceuticals and functional foods. Accelerated adoption is supported by the region's highly developed healthcare infrastructure, growing investments in probiotic innovation, and biofilm-based delivery systems. Market penetration is further increased by rising awareness of immunity, gut health, and customized nutrition, particularly through high-end supplements and fortified foods. Moreover, the availability of products is also being increased by strategic alliances between pharmaceutical, food, and biotech companies.

Key players in the market

Some of the key players in Probiotic Biofilm Protectors Market include Chr Hansen Holding AS, Kerry Group PLC, DuPont de Nemours, Inc., BioGaia AB, Nestle S.A., DSM-Firmenich, Lifeway Foods Inc., Yakult Honsha Co., Ltd., Danone SA, Lallemand Inc., General Mills Inc., PepsiCo Inc., Nuron Biotech Inc., Walvax Biotechnology Co., Ltd., Morinaga Milk Industry Co. Ltd, Sanzyme Biologics Pvt. Ltd. and Now Foods.

Key Developments:

In May 2025, Nestle SA, the parent company of Nestle India, has made a financial investment in India-based pet food company, Drools Pet Food Private Limited, marking its first such investment in the country. Under this agreement, Nestle S.A will pick up a minority stake in Drools for an undisclosed amount. This comes at a time when Drool is positioning itself as a global pet food brand with Indian roots.

In November 2024, Kerry Group plc announced that it has entered into an agreement with Kerry Co-Operative Creameries Limited to sell Kerry Dairy Holdings Limited to the Co-Op for a total expected consideration of €500 million. Kerry Dairy Ireland consists of Dairy Consumer Products, with its leading range of well-loved brands across cheese, cheese snacks, dairy snacks, and dairy spreads, which can be found in chilled cabinets across retailers in the UK and Ireland.

In October 2024, DuPont and Zhen Ding Technology Group announced they have entered into a strategic cooperation agreement in advanced printed circuit board (PCBs) technology. Through this strategic partnership, DuPont and Zhen Ding will work to enhance end-user applications, advance cutting-edge research and development, improve material performance, and promote the sustainable development of the electronics sector.

Product Types Covered:

  • Probiotic Strains
  • Postbiotics & Synbiotics
  • Delivery Formats

Applications Covered:

  • Medical devices Biofilm Protection
  • Food and Beverages Preservation
  • Agricultural Products Protection
  • Environmental and Industrial Cleaning
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Pharmaceutical Companies
  • Consumer Health & Wellness
  • Research Institutions
  • Personal Care and Cosmetics
  • Veterinary Clinics & Animal Health Companies

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Probiotic Biofilm Protectors Market, By Product Type

  • 5.1 Introduction
  • 5.2 Probiotic Strains
    • 5.2.1 Bacillus Strains
    • 5.2.2 Lactobacillus Strains
    • 5.2.3 Bifidobacterium Strains
  • 5.3 Postbiotics & Synbiotics
  • 5.4 Delivery Formats
    • 5.4.1 Capsules
    • 5.4.2 Powders
    • 5.4.3 Functional Foods
    • 5.4.4 Topical Gels/Creams
    • 5.4.5 Liquid Suspensions
    • 5.4.6 Microencapsulated Forms

6 Global Probiotic Biofilm Protectors Market, By Application

  • 6.1 Introduction
  • 6.2 Medical devices Biofilm Protection
  • 6.3 Food and Beverages Preservation
  • 6.4 Agricultural Products Protection
  • 6.5 Environmental and Industrial Cleaning
  • 6.6 Other Applications
    • 6.6.1 Aquaculture
    • 6.6.2 Veterinary Health
    • 6.6.3 Oral Hygiene
    • 6.6.4 Textile & Surface Coatings

7 Global Probiotic Biofilm Protectors Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals & Clinics
  • 7.3 Pharmaceutical Companies
  • 7.4 Consumer Health & Wellness
  • 7.5 Research Institutions
  • 7.6 Personal Care and Cosmetics
  • 7.7 Veterinary Clinics & Animal Health Companies

8 Global Probiotic Biofilm Protectors Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Chr Hansen Holding AS
  • 10.2 Kerry Group PLC
  • 10.3 DuPont de Nemours, Inc.
  • 10.4 BioGaia AB
  • 10.5 Nestle S.A.
  • 10.6 DSM-Firmenich
  • 10.7 Lifeway Foods Inc.
  • 10.8 Yakult Honsha Co., Ltd.
  • 10.9 Danone SA
  • 10.10 Lallemand Inc.
  • 10.11 General Mills Inc.
  • 10.12 PepsiCo Inc.
  • 10.13 Nuron Biotech Inc.
  • 10.14 Walvax Biotechnology Co., Ltd.
  • 10.15 Morinaga Milk Industry Co. Ltd
  • 10.16 Sanzyme Biologics Pvt. Ltd.
  • 10.17 Now Foods

List of Tables

  • Table 1 Global Probiotic Biofilm Protectors Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Probiotic Biofilm Protectors Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Probiotic Biofilm Protectors Market Outlook, By Probiotic Strains (2024-2032) ($MN)
  • Table 4 Global Probiotic Biofilm Protectors Market Outlook, By Bacillus Strains (2024-2032) ($MN)
  • Table 5 Global Probiotic Biofilm Protectors Market Outlook, By Lactobacillus Strains (2024-2032) ($MN)
  • Table 6 Global Probiotic Biofilm Protectors Market Outlook, By Bifidobacterium Strains (2024-2032) ($MN)
  • Table 7 Global Probiotic Biofilm Protectors Market Outlook, By Postbiotics & Synbiotics (2024-2032) ($MN)
  • Table 8 Global Probiotic Biofilm Protectors Market Outlook, By Delivery Formats (2024-2032) ($MN)
  • Table 9 Global Probiotic Biofilm Protectors Market Outlook, By Capsules (2024-2032) ($MN)
  • Table 10 Global Probiotic Biofilm Protectors Market Outlook, By Powders (2024-2032) ($MN)
  • Table 11 Global Probiotic Biofilm Protectors Market Outlook, By Functional Foods (2024-2032) ($MN)
  • Table 12 Global Probiotic Biofilm Protectors Market Outlook, By Topical Gels/Creams (2024-2032) ($MN)
  • Table 13 Global Probiotic Biofilm Protectors Market Outlook, By Liquid Suspensions (2024-2032) ($MN)
  • Table 14 Global Probiotic Biofilm Protectors Market Outlook, By Microencapsulated Forms (2024-2032) ($MN)
  • Table 15 Global Probiotic Biofilm Protectors Market Outlook, By Application (2024-2032) ($MN)
  • Table 16 Global Probiotic Biofilm Protectors Market Outlook, By Medical devices Biofilm Protection (2024-2032) ($MN)
  • Table 17 Global Probiotic Biofilm Protectors Market Outlook, By Food and Beverages Preservation (2024-2032) ($MN)
  • Table 18 Global Probiotic Biofilm Protectors Market Outlook, By Agricultural Products Protection (2024-2032) ($MN)
  • Table 19 Global Probiotic Biofilm Protectors Market Outlook, By Environmental and Industrial Cleaning (2024-2032) ($MN)
  • Table 20 Global Probiotic Biofilm Protectors Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 21 Global Probiotic Biofilm Protectors Market Outlook, By Aquaculture (2024-2032) ($MN)
  • Table 22 Global Probiotic Biofilm Protectors Market Outlook, By Veterinary Health (2024-2032) ($MN)
  • Table 23 Global Probiotic Biofilm Protectors Market Outlook, By Oral Hygiene (2024-2032) ($MN)
  • Table 24 Global Probiotic Biofilm Protectors Market Outlook, By Textile & Surface Coatings (2024-2032) ($MN)
  • Table 25 Global Probiotic Biofilm Protectors Market Outlook, By End User (2024-2032) ($MN)
  • Table 26 Global Probiotic Biofilm Protectors Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 27 Global Probiotic Biofilm Protectors Market Outlook, By Pharmaceutical Companies (2024-2032) ($MN)
  • Table 28 Global Probiotic Biofilm Protectors Market Outlook, By Consumer Health & Wellness (2024-2032) ($MN)
  • Table 29 Global Probiotic Biofilm Protectors Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 30 Global Probiotic Biofilm Protectors Market Outlook, By Personal Care and Cosmetics (2024-2032) ($MN)
  • Table 31 Global Probiotic Biofilm Protectors Market Outlook, By Veterinary Clinics & Animal Health Companies (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.